CSX vs JCI

CSX presents a significant valuation disconnect, with a Piotroski F-Score of 4/9 indicating only stable health and a current price of $43.37 that vastly exceeds both the Graham Number ($15.61) and Intrinsic Value ($10.71). While the company maintains strong operating margins (32.72%) and ROE (22.51%), growth has stalled with negative YoY revenue and earnings growth. The stock has experienced a massive 1-year price surge of 60.3%, yet the technical trend has shifted to heavily bearish (10/100), suggesting a potential peak. Overall, the high PEG ratio of 3.74 indicates the market is paying a steep premium for a company with stagnant growth.

Johnson Controls International (JCI) trades at a premium valuation with strong recent earnings growth and solid profitability, but faces headwinds from stretched multiples, weakening near-term EPS momentum, and bearish insider activity. While the company has delivered consistent quarterly beats over the past six years—evidenced by a 20.0% Q/Q EPS growth and 3.64% average surprise over the last four quarters—its forward P/E of 28.33 and current P/E of 44.97 are well above the sector average of 31.50, raising concerns about near-term upside. The stock has significantly outperformed with a 1Y return of +41.2% and 5Y return of +189.6%, yet momentum has cooled recently (-2.9% over 1W). Analysts maintain a 'buy' recommendation with a $129.11 target implying ~8.7% upside, but insider selling worth $4.04M over the last six months signals caution at current levels.